These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9588187)

  • 21. Interleukin-6 dependent induction of the cyclin dependent kinase inhibitor p21WAF1/CIP1 is lost during progression of human malignant melanoma.
    Flørenes VA; Lu C; Bhattacharya N; Rak J; Sheehan C; Slingerland JM; Kerbel RS
    Oncogene; 1999 Jan; 18(4):1023-32. PubMed ID: 10023678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
    Kokontis JM; Hay N; Liao S
    Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Partial phenotypic reversion of HeLa cells by long-term interferon-alpha treatment.
    López Ocejo O; Perea SE; Reyes A; Vigoa L; López Saura P
    J Interferon Res; 1993 Oct; 13(5):369-75. PubMed ID: 8301158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential modulation of cyclin-dependent kinase inhibitor p27Kip1 by negative signaling via the antigen receptor of B cells and positive signaling via CD40.
    Han H; Nomura T; Honjo T; Tsubata T
    Eur J Immunol; 1996 Oct; 26(10):2425-32. PubMed ID: 8898956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of p27Kip1 in the G1- and S/G2-phase lengthening mediated by glucocorticoids in normal human lymphocytes.
    Baghdassarian N; Peiretti A; Devaux E; Bryon PA; Ffrench M
    Cell Growth Differ; 1999 Jun; 10(6):405-12. PubMed ID: 10392902
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-alpha elicits downregulation of human papillomavirus 18 mRNA in HeLa cells by selective repression of endogenous viral transcription.
    Perea SE; López-Ocejo O; García-Milian R; Araña MJ
    J Interferon Cytokine Res; 1995 Jun; 15(6):495-501. PubMed ID: 7553218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells.
    Harvat BL; Seth P; Jetten AM
    Oncogene; 1997 May; 14(17):2111-22. PubMed ID: 9160891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis and growth inhibition of squamous carcinoma cells treated with interferon-alpha, IFN-beta and retinoic acid are associated with induction of the cyclin-dependent kinase inhibitor p21.
    Giandomenico V; Vaccari G; Fiorucci G; Percario Z; Vannuchi S; Matarrese P; Malorni W; Romeo G; Affabris GR
    Eur Cytokine Netw; 1998 Dec; 9(4):619-31. PubMed ID: 9889406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate.
    Liang YC; Lin-Shiau SY; Chen CF; Lin JK
    J Cell Biochem; 1999 Oct; 75(1):1-12. PubMed ID: 10462699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.
    Lee TH; Chuang LY; Hung WC
    Oncogene; 1999 Jul; 18(29):4269-74. PubMed ID: 10435640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth inhibitory effect of interferon-beta is associated with the induction of cyclin-dependent kinase inhibitor p27Kip1 in a human gastric carcinoma cell line.
    Kuniyasu H; Yasui W; Kitahara K; Naka K; Yokozaki H; Akama Y; Hamamoto T; Tahara H; Tahara E
    Cell Growth Differ; 1997 Jan; 8(1):47-52. PubMed ID: 8993833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
    Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
    Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p27Kip1 is the key mediator of phenylacetate induced cell cycle arrest in human prostate cancer cells.
    Onishi T; Yamakawa K; Franco OE; Suzuki R; Kawamura J
    Anticancer Res; 2000; 20(5A):3075-81. PubMed ID: 11062725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
    Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
    Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The HPV-16 E7 oncogene sensitizes malignant cells to IFN-alpha-induced apoptosis.
    Thyrell L; Sangfelt O; Zhivotovsky B; Pokrovskaja K; Wang Y; Einhorn S; Grandér D
    J Interferon Cytokine Res; 2005 Feb; 25(2):63-72. PubMed ID: 15695927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway.
    Kawada M; Yamagoe S; Murakami Y; Suzuki K; Mizuno S; Uehara Y
    Oncogene; 1997 Aug; 15(6):629-37. PubMed ID: 9264403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiproliferative function of p27kip1 is frequently inhibited in highly malignant Burkitt's lymphoma cells.
    Barnouin K; Fredersdorf S; Eddaoudi A; Mittnacht S; Pan LX; Du MQ; Lu X
    Oncogene; 1999 Nov; 18(46):6388-97. PubMed ID: 10597239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of the cyclin-dependent kinase inhibitor p27Kip1 in negative signaling through the antigen-receptor of B lymphocytes.
    Han H; Nomura T; Honjo T; Tsubata T
    Leukemia; 1997 Apr; 11 Suppl 3():367-9. PubMed ID: 9209392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
    Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
    Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of peroxisome proliferator-activated receptor gamma by troglitazone inhibits cell growth through the increase of p27KiP1 in human. Pancreatic carcinoma cells.
    Motomura W; Okumura T; Takahashi N; Obara T; Kohgo Y
    Cancer Res; 2000 Oct; 60(19):5558-64. PubMed ID: 11034103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.